Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells

Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administration of escalating cell doses improves the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremm, Melanie, Pfeffermann, Lisa-Marie, Cappel, Claudia, Katzki, Verena, Erben, Stephanie, Betz, Sibille, Quaiser, Andrea, Merker, Michael, Bonig, Halvard, Schmidt, Michael, Klingebiel, Thomas, Bader, Peter, Huenecke, Sabine, Rettinger, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554420/
https://www.ncbi.nlm.nih.gov/pubmed/31214182
http://dx.doi.org/10.3389/fimmu.2019.01218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554420/
https://www.ncbi.nlm.nih.gov/pubmed/31214182
http://dx.doi.org/10.3389/fimmu.2019.01218

Ejemplares similares